Exchange: NASDAQ·Updated 05:40 PM EDT
ACXP logo

ACXP Acurx Pharmaceuticals Inc

$1.04
$0.03
(2.80%)
Today
Closed $1.04
$0.0002
(0.02%)
After Hours
EarningsNov 12
Mkt Cap$5.78M
Vol63,194.00

About ACXP

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.
49

Neutral Sentiment

How do you feel about ACXP?

Billywilly4
$ACXP ignore the fud bots nobody is selling. We are in the final stage before liftoff. Cifbezy is the real deal. Even the biofilm data shows it is more potent than the standard treatments plus it promotes healthy terrain with less primary bile acids which is what causes sporulation and recurrence. Did you guys even read the publications? Plus pipeline for pneumonia and mrsa and about 100 other gram positive bacteria....PT 1000 2030
3
PUMPLESTILTSKIN
$ACXP at .99 they can do a reverse split, but at 0.84 they fall under 5M market cap and will have to delist. at down 0.10 per week this thing should be delisted by mid November. Only thing that can stop it is real nondilutive funding such as a grant, funding through partnership, etc. With only 1 patient done in 2 months (out of 20 patients). The good news for Luci is that he can get delisted, and slow recruiting activities down to a crawl. This will cut recruiting costs, helping them to take their salaries longer. They only have about 10M in cash, which historically is about a year of runway. They can get another 5 or 6 patients enrolled in that time, or they can enroll one or two and stretch the cash out for 18+ months to pay themselves. They are in the endgame now. Luci and friends need to figure out how to squeeze as much cash as possible out of this desiccated corpse of a company. The shareholders will suffer. Science will suffer. Luci will profit.
3
focafoca99
$ACXP signed a 12-month media series with New to The Street to broadcast monthly interviews on its antibiotic pipeline.
2
Cpictures
$ACXP Buy shares in this "company" to fund the retirement accounts of the two old men who are the only employees. Where do you think the money from their quarterly offerings go? Help those poor old men afford their country club dues to help the stock avoid delisting.
1
Betchips
$ACXP looking for a position here. Looks like plague stocks might be good to get into right now.
1
PUMPLESTILTSKIN
$ACXP They will delist at 0.89 (5M market cap) which is about 30 days away if current price trajectory holds. Luci is not worthy of Ibezapolstat. shame

Advertisement|Remove ads.